

For the treatment of acute schizophrenia in adults and adolescents.The use of Abilify Oral Solution (Aripiprazole) is for the treatment of the following conditions: This drug is also a partial agonist at the 5-HT1A receptor, and like other atypical antipsychotics display an antagonistic profile at the 5-HT2A receptor. Unlike other antipsychotics (for example, clozapine, olanzapine, quetiapine, ziprasidone, and risperidone ) which work as D2 receptor antagonists, Aripiprazole acts as a partial agonist of D2. In addition, this drug is also used to treat depression, tic disorders, and irritability related to autism.Īripiprazole is a quinolinone derivative antipsychotic agent. FactoryĪbilify Oral Solution is marketed in the following packages:Įach package of Abilify Oral Solution contains the active substance (generic name) as follows:Īn overview of active substances (generic names)Īripiprazole is an atypical antipsychotic drug used to treat schizophrenia and bipolar disorder. The following is complete information about Abilify Oral Solution accompanied by links to other brands of drugs with the same generic name. Abilify Oral Solution contains Aripiprazole, a drug that includes an atypical antipsychotic quinolinone derivative. The information below is only an overview of the drug Abilify Oral Solution.Ībilify Oral Solution is a schizophrenic drug, bipolar disorder, depression, and irritability related to autism. CAUTION: We do not ship Abilify Oral Solution medicines.
